SeLux Diagnostics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- February 28, 2022
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Funding Amount:
- $50,000,000
Company Info
- Company Description
- SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
- Market
- Diagnostic Testing
- Location
- Charlestown, MA, USA
- Coinvestors
- Northpond Ventures, RA Capital Management, Sands Capital, Schooner Capital